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Background: Nutritional status is an important factor affecting a patient’s clinical outcomes. 3 
Early identification of patients who are at risk of malnutrition is important to improve clinical 4 
outcomes and reduce health cost. Malnutrition universal screening tool (MUST) has been 5 
recommended as part of the routine nursing assessment for all patients at hospital admission.  6 
Objective: The aim of this study was to examine the association between nutritional status 7 
(MUST), systemic inflammatory response (SIR), body composition, and clinical outcomes in 8 
patients undergoing surgery for colorectal cancer. 9 
Methods: The malnutrition risk was examined using MUST in patients admitted for surgery 10 
for colorectal cancer between March 2013 and June 2016. Pre-operative CT scans were used 11 
to define the body composition. The presence of SIR was evidenced by the modified 12 
Glasgow prognostic score (mGPS) and neutrophil to lymphocyte ratio (NLR). Post-operative 13 
complications, severity of complication, length of hospital stay and mortality were considered 14 
as outcome measures.  15 
Result: The study included 363 patients (199 males, 164 females), 21% of the patients 16 
presented with a medium or high nutritional risk. There were significant associations between 17 
MUST and subcutaneous adiposity (p<0.001), visceral obesity (p<0.001) and low SMI 18 
(p<0.001). No statistically significant association was identified between MUST score and 19 
presence of any complication or severity of complication. On multivariate analysis, MUST 20 
remained independently associated with the length of hospital stay [OR=2.17 (95% CI 21 
1.45,3.26) p<0.001].  Kaplan–Meier survival curves showed an increased number of deaths 22 
for patients at medium or high risk of malnutrition (p<0.001). This association was found to 23 
be independent of other confounding factors [HR=1.45 (95% CI 1.06,1.99) p=0.020].  24 
Conclusion:  MUST score is an independent marker of risk in those undergoing surgery for 25 
colorectal cancer surgery and should remain a key part of preoperative assessment.  26 
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Colorectal cancer is the third most common cancer and the fourth leading cause of cancer-33 
related deaths worldwide, and its burden is expected to increase by 60% to more than 2.2 34 
million new cases and 1.1 million cancer deaths by 2030 (1). In the United Kingdom in 2016, 35 
more than 41,000 patients are diagnosed and almost 16,500 patients die from colorectal 36 
cancer (2). Postoperative complications occur in up to one-third of patients undergoing 37 
colorectal procedures (3). Patients with complications have been shown to be at higher risk 38 
for mortality (4). 39 
Nutritional status is an important factor affecting patient’s clinical outcomes. Malnutrition 40 
has been shown to be associated with adverse postoperative outcomes of morbidity and 41 
mortality in patients with gastrointestinal cancer (5,6). Indeed, the presence of malnutrition 42 
can alter immune responses and impair wound healing in surgical patients (7). 43 
Early identification of patients who are malnourished or at risk of becoming malnourished, 44 
and those who would benefit from specific nutritional support, is vital to reduce the risk of 45 
surgical complications, improve clinical outcomes and reduce health cost. According to the 46 
British Association for Parenteral and Enteral Nutrition (BAPEN) recommendation, the 47 
screening method should be: simple and understandable, rapid to implement, and validated 48 
for hospital use (8). Several nutritional screening tools have been developed for this purpose, 49 
including the Malnutrition Universal Screening Tool (MUST). MUST identifies patients who 50 
are malnourished or at risk of developing malnutrition based on assessment of body mass 51 
index (BMI), unintentional weight loss in the preceding three to six months, and the presence 52 
of an acute disease resulting in absence of dietary intake for more than five days (9) 53 
Subsequent management guidelines have followed, based on the overall malnutrition risk 54 
(MUST) score.  55 
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Published studies have been conducted to assess nutritional status in oncologic patients using 56 
different nutritional screening tools such as subjective global assessment (SGA), malnutrition 57 
screening tool (MST) and nutritional risk screening (NRS 2002) (10). MUST is now used in 58 
most of the UK as part of the routine nursing assessment for all patients admitted to hospital 59 
(11), However, to our knowledge no studies have examined the relationship between MUST, 60 
body composition, and systemic inflammatory responses. The aim of the present study was to 61 
examine these associations, and to relate MUST score to clinical outcomes after surgery for 62 




















Patients and Methods 81 
Patients  82 
Consecutive patients who underwent potentially curative resection for colorectal cancer 83 
between March 2013 and June 2016 were included. All procedures were performed at 84 
Glasgow Royal Infirmary. Those patients with a preoperative recorded MUST score, 85 
preoperative CT scan, and documentation reporting the presence or absence of post-operative 86 
complications were included. Data regarding the nature, severity and management of 87 
complications were retrospectively classified using the Clavien-Dindo grade, where 0 is no 88 
complication, 1 is any deviation from the normal post-operative course without the need for 89 
pharmacological treatment or surgical, endoscopic and radiological interventions, 2 is 90 
requiring pharmacological treatment with drugs other than such allowed for grade 1 91 
complications, 3 is requiring surgical, endoscopic or radiological intervention, 4 is a life 92 
threatening complication (including CNS complications) requiring IC/ICU management, 5 is 93 
the death of a patient (12).  Patient comorbidity was classified using the American Society of 94 
Anesthesiologists (ASA) grading system.  ASA 1 a patient with normal health, ASA 2 a 95 
patient with mild systemic disease, ASA 3 a patient with severe systemic disease and ASA 4 96 
a patient with severe systemic disease that is a constant threat to life. 97 
All data were collected prospectively in a database, anonymised, and were subsequently 98 
analysed. Any uncertainties were addressed by review of electronic and/or physical case 99 
notes. 100 
Malnutrition risk assessment  101 
The MUST scores were recorded in patient notes, using a dedicated pro forma, by clinical 102 
nursing staff, within 24 h of admission. MUST incorporates three components to determine 103 
the overall risk for malnutrition (Figure1): current weight status using BMI, unintentional 104 
weight loss, and acute disease effect that has induced a phase of nil per mouth for > 5 days. 105 
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Each parameter can be rated as 0, 1, or 2. Overall risk for malnutrition is established as low 106 
(score = 0), medium (score = 1), or high (score ≥2).  107 
Body composition 108 
CT images were obtained at the level of the third lumbar vertebra. Patients whose scans were 109 
taken 3 months or more prior to their surgery were excluded from the study. The median and 110 
range for the interval between CT scanning and operation was 0.91 months (0.03-2.83) with 111 
78% of scans carried out within 30 days of operation. Scans with significant movement 112 
artefact or missing region of interest were not considered for inclusion. Each image was 113 
analysed using a free-ware program [NIH Image J version 1.47 (24)]. Region of interest 114 
(ROI) measurements were made of visceral adipose tissue, subcutaneous adipose tissue and 115 
skeletal muscle areas (cm
2
) using standard Hounsfield Unit (HU) ranges (adipose tissue -190 116 
to -30, and skeletal muscle -29 to +150). These were then normalised for height
2
 to create 117 

















). Skeletal 119 
muscle radiodensity (SMD, HU) was measured from the same ROI used to calculate SMI, as 120 
its mean HU. Visceral obesity was defined as VFA >160cm
2
 for male patients and >80cm
2
 121 









 in females (14). Sarcopenia was described by Caan and 123 























 if 125 
BMI>30kg/m
2
 in female patients (15). Low SMD was defined by SMD <41HU in patients 126 
with BMI <25kg/m
2
 and <33HU in patients with BMI >25kg/m
2
 (25). 127 
Inflammatory markers  128 
Serum CRP (mg/L) and albumin (g/L) concentrations were measured by routine laboratory 129 
procedures with an automated analyzer (Architect; Abbott Diagnostics, Maidenhead, UK). 130 
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The limit of detection for CRP was 0.1 mg/L. Intraassay imprecision was <4%. The 131 
laboratory participated in external quality assurance/ proficiency testing programs, the A, B 132 
and C scores were within the EQA (NEQAS) targets throughout the time period of the study. 133 
Performance was acceptable throughout, which indicated that methodologic changes did not 134 
result in any bias. The presence of preoperative systemic inflammatory response was 135 
evidenced by an mGPS and NLR. The mGPS was derived as the following; patients with a 136 
normal C-reactive protein (<10mg/L) were allocated a score of 0, those with an elevated C-137 
reactive protein (>10 mg/L) allocated a score 1, and those with an elevated C-reactive protein 138 
(>10 mg/L) and hypoalbuminaemia (<35 g/L) were allocated a score of 2 (16). The 139 
neutrophil lymphocyte ratio (NLR) was calculated for each patient for whom preoperative 140 
neutrophil and lymphocyte counts were available. Values < than 3 considered normal, 3-5 141 
moderate and >5 were considered raised (26).  142 
Survival  143 
The cause and date of death were confirmed with the Registrar General (Scotland) until 30 144 
June 2018, which served as the censor date. Informed consent was obtained from patients 145 
prior to surgery. Ethical approval was granted by the West of Scotland Research Ethics 146 
Committee, Glasgow.   147 
Statistical analysis: 148 
In the present study no formal power calculation was carried out since low SMI has been 149 
shown to be associated with overall survival (primary endpoint) in smaller and similar sized 150 
cohorts of patients undergoing surgery for colorectal cancer (19, 27). Secondary outcome 151 
measures were length of hospital stay and post-operative complications 152 
Categorical variables were analysed using Chi-square test for linear-by-linear association. 153 
Where there was a significant association on Chi-square analysis, pairwise comparisons were 154 
carried out to detect where the differences in proportions were. Missing data were excluded 155 
10 
 
from analysis on a variable by variable basis. Due to the number of statistical comparisons 156 
carried out (~40) a P value <0.001 was considered statistically significant. Mortality within 157 
30 days of the index procedure or during the index admission were excluded from subsequent 158 
survival analysis. The time between the date of surgery and the date of death of any cause 159 
was used to define overall survival (OS). The Cox regression hazard model was applied to 160 
assess the ability of the MUST to predict survival. Those variables associated to a degree of 161 
p<0.1 at univariate analysis were entered into a backward conditional multivariate model.  162 
Length of hospital stay was classified as binary variable (<7 vs >7 days) and then analysed 163 
using univariate and multivariate binary logistic regression.  164 
 Statistical analysis was performed using SPSS software (Version 21.0. SPSS Inc., Chicago, 165 








Results:  172 
 173 
In total 483 patients were identified as having undergone potentially curative surgery for 174 
colorectal cancer. Of these, 120 were excluded due to missing MUST score, or clinical and 175 
pathological data. A total of 363 patients were included in the final analysis. There were 199 176 
males and 164 females. The mean (±SD) age was 66 ± 12 y and BMI 27.6 ± 6.4. The 177 
majority of patients had ASA grade 1 and 2 comorbidity (69%), colon cancer (62%) and had 178 
TNM stage 0-2 disease (64%). The majority of patients had subcutaneous (63%) and visceral 179 
(72%) adiposity, low SMI (50%) and low SMD (61%). The majority of patients had a mGPS 180 
(76%) and NLR (51%) in the normal range. The majority of patients had no complication 181 
type (63%) and severity measured by Clavien-Dindo grade (66%), had a hospital stay more 182 
than 7 days (54%) and were alive at 3 years (79%).   183 
MUST and patients’ characteristics 184 
A total of 288 patients had a MUST 0 (79%, Low risk), 31 had MUST 1 (9%, medium risk), 185 
and 44 had a MUST > 2 (12%, high risk). 186 
The associations of nutritional status classified by MUST with patients’ characteristics, body 187 
composition, systemic inflammatory response and colorectal cancer outcomes are presented 188 
in Table 1. Since TNM stage 4 disease is commonly associated with malnutrition risk the 189 
analysis was repeated after excluding the patients (n=13). The results of the analysis did not 190 
change materially. There were significant associations between MUST, age and BMI.  191 
Around 39% of patients with MUST score 2 were older than 74y (p<0.001), and BMI: All 192 
underweight patients had MUST score ≥1 and only 7% of patients with MUST score 2 were 193 
obese. 194 
There were no association with sex, ASA, tumour site and stage.  195 
MUST and body composition 196 
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There were significant associations between MUST and subcutaneous adiposity (p<0.001), 197 
visceral obesity (p<0.001) and low SMI (p<0.001). Specifically, 42% of patients with a 198 
MUST score 2 had subcutaneous adiposity compared with 86% of patients with a MUST 199 
score of 0 (p<0.001). Also, 38% of patients with MUST score 2 had visceral obesity 200 
compared with 80% of patients with a MUST score 0 (p<0.001). Finally, 76% of patients 201 
with MUST score 2 had low SMI compared with 45% of patients with a MUST score 0 202 
(p=0.001).  203 
MUST and systemic inflammatory response 204 
There were significant associations between MUST and mGPS (p<0.001). Specifically, 36% 205 
of patients with a MUST score 2 had a mGPS of 2 compared with 8% of patients with a 206 
MUST score of 0 (p<0.001).   207 
MUST and clinical outcome 208 
There were significant associations between MUST and length of hospital stay (p<0.001) and 209 
3 year survival (p=0.002). Specifically, 78% of patients with a MUST score 2 had a length of 210 
stay >7 days compared with 49% of patients with a MUST score of 0 (p=0.002).  Also, 33% 211 
of patients with MUST score 2 were dead at 3 years compared with 17% of patients with a 212 
MUST score 0 (p=0.001).   213 
Length of hospital stay  214 
The variables associated with the length of hospital stay are presented in Table 2. On 215 
univariate logistic regression, age (p=0.019), ASA (p=0.026), BMI (p=0.045), MUST 216 
(p=0.001),visceral obesity (p=0.094), mGPS (p =0.043), NLR(p=0.002), and complication 217 
(p<0.001) were significantly associated with length of hospital stay >7 days. Multivariate 218 
analysis showed that MUST [OR=2.17 (95% CI 1.45, 3.26) p<0.001] and complication 219 
[OR=11.04 (95% CI 5.96,20.44) p<0.001] were independently associated with length of 220 




There was no significant association between MUST score and either the presence of 223 
complications or their severity. 224 
Survival  225 
A total of 239 patients were alive at the censor date. Death due to any cause occurred in 82 226 
patients with 51 being cancer specific.  The median survival was 38 months (range 1-122 227 
months). After exclusion of thirty-day postoperative mortality (1%), there was a significant 228 
association between MUST score and overall survival (p<0.001). Kaplan–Meier curves 229 
(Figure 2) showed an increased number of deaths for patients at medium or high risk of 230 
malnutrition (log rank test, p<0.001).  231 
On univariate cox regression survival analysis (Table 3), age (p<0.001), sex (p=0.048), ASA 232 
(p<0.001), TNM stage (p<0.001), BMI (p=0.005), MUST (p<0.001), subcutaneous adiposity 233 
(p=0.033), low SMD (p=0.015), mGPS (p=0.005), and NLR (p=0.026) were significantly 234 
associated with overall survival. Multivariate analysis showed that age [HR=1.45 (95% CI 235 
1.05,2.01) p=0.023], TNM stage [HR=2.19(95% CI 1.56,3.08) p<0.001],  MUST [HR=1.45 236 
(95% CI 1.06,1.99) p=0.020], and NLR [HR=1.39(95% CI 1.01,1.90) p=0.037] were 237 





Discussion  241 
 242 
The results of the present study show for the first time that there was a significant association 243 
between pre-operative nutritional status (MUST), subcutaneous adiposity, visceral obesity 244 
low SMI, systemic inflammatory response and clinical outcomes after surgery of colorectal 245 
cancer. Specifically, the majority of patients with a MUST score of 2 were underweight 246 
(54%) but only 19% in those with a score of 1.  Similarly, there was low adiposity in 58% 247 
and 40% respectively, low SMI in 76% and 60% respectively and a mGPS 2 in 36% and 31% 248 
respectively. Also, MUST was independently associated with length of hospital stay and 249 
overall survival. Therefore, routine MUST assessment usefully characterises important 250 
phenotypes associated with malnutrition including loss of skeletal muscle mass and the 251 
presence of a systemic inflammatory response in patients with primary operable colorectal 252 
cancer. 253 
The present results are consistent with previous studies that have shown a relationship 254 
between the presence of a systemic inflammatory response and the loss of skeletal muscle 255 
(sarcopenia) (17,18,19&20) in primary operable colorectal cancer.  Indeed, the presence of a 256 
systemic inflammatory response is now recognised as a key hallmark of progressive 257 
nutritional decline in patients with cancer (21).  It is now clear that nutritional assessment 258 
tools such as MUST may also reflect the systemic inflammatory status in patients with 259 
cancer. To date, although other studies have reported that nutritional screening tools are 260 
associated with poor post-operative outcomes in patients with gastrointestinal cancer (5,6), 261 
few studies have clearly delineated the prognostic value of nutritional screening tools 262 
independent of potential confounding factors.  The results of the present study show that 263 
MUST was independently associated with length of hospital stay and long term survival.  In 264 
contrast, MUST was not associated with the development and severity of post-operative 265 
complications.  266 
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It may be that poor nutritional status per se is a relatively weak determinant of post-operative 267 
complications in these patients.  While this might appear to be counterintuitive, in terms of 268 
the present study cohort MUST clearly identifies the underweight (BMI<18.5kg/m
2
).  269 
However, post-operative complications have been consistently associated with obesity 270 
(BMI>30kg/m
2
) (22) and it may be that in the present cohort where approximately 10% were 271 
underweight and approximately 30% were obese that obesity was the main driver of post-272 
operative complications. Indeed, visceral obesity has been reported to be independently 273 
associated with post-operative complications (23). 274 
In contrast, MUST was independently associated with length of hospital stay and overall 275 
survival.  The basis of these associations may be more obvious.  Patients identified at 276 
nutritional risk (ie underweight) are more likely to receive dietetic input and have delayed 277 
discharge.  Patients with cancer and underweight are likely to be cachectic and this has long 278 
been recognised to compromise long term outcomes (21). 279 
 280 
The implications of the present observations are important.  MUST uses three criteria to 281 
assess the overall risk for malnutrition and it appears that each of the criteria can 282 
independently predict clinical outcome (9). Furthermore, it appears to compare well with 283 
other nutritional screening tools such as NRI, MST and SGA for defining nutritional status 284 
and it has been concluded that MUST and SGA are effective in the outpatient setting (10).  285 
However, the interpretation of nutritional screening tools such as MUST is of major 286 
importance since if such patients are identified to be at nutritional risk there may be an 287 
assumption that they are likely to benefit from a nutritional intervention.  If, in patients with 288 
cancer, MUST reflects, in part, the cachectic process including the systemic inflammatory 289 
response then it may be that down regulation of the systemic inflammatory response would 290 
be of more benefit (28). There is also the possibility to treat the malnutrition and down 291 
16 
 
regulate the systemic inflammatory response. Indeed, recently updated nutritional strategies 292 
for cancer patients now suggest considering nutrition with anti-catabolic and inflammation-293 
suppressing ingredients such as arginine, omega-3-polyunsaturated fatty acids, and glutamine 294 
(21). A growing number of studies have evaluated the use of such immunonutrients in 295 
patients with cancer undergoing surgery.  For example, a systematic review and meta-296 
analysis of 20 studies with a total of 2005 gastrointestinal cancer patients reported that, 297 
compared with a standard feed, an immune enhancing feed was associated with lower 298 
infective complication rates and length of hospital stay (29&30)  More clinical trials in the 299 
context of the systemic inflammatory response are required. 300 
 301 
The main limitation of the present study is that it was a retrospective study of patients in a 302 
single institution and only patients with an available MUST score were included in the 303 
analysis. However, this study, is to our knowledge, the first to examine the association 304 
between a preoperative nutritional assessment tool (MUST), body composition and systemic 305 
inflammation in large number of patients undergoing surgery for primary operable cancer.  306 
 307 
In summary, there was a significant association between pre-operative nutritional status 308 
(MUST), body composition, systemic inflammatory response and clinical outcomes after 309 
surgery of colorectal cancer. These observations warrant confirmation in other clinical 310 
scenarios where nutritional assessment tools are routinely used. 311 
 312 
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Nutrition risk   MUST  
 
 








Age <65 141(39) 124 (43 ) 6(19) 11(25) <0.001 
65 – 74 136(37) 108(38) 12(39) 16(36) 
>74 86(24) 56(19) 13(42) 17(39) 
Sex Male 199(55) 163(57) 13(42) 23(52) 0.334 
Female 164(45) 125(43) 18(58) 21(48) 
BMI (kg/m2) 
 
Underweight (<20) 30(8) 0(0) 6(19) 24(54) <0.001 
Normal 20-24.9 98(27) 75(26) 14(45) 9(20) 
Overweight 25-29.9 124(34) 109(38) 7(23) 8(18) 
Obese (>30)  111(31) 104(36) 4(13) 3(7) 
ASA grade 1 89(25) 72(26) 6(21) 11(25) 0.036 
2 155(44) 128(46) 14(48) 13(30) 
3 96(27) 74(26) 7(24) 15(34) 
4 13(4) 6(2) 2(7) 5(11) 
Tumor site  Colon 225(62) 173(60) 23(74) 29(66) 0.264 
Rectum  137(38)  114(34) 8(26) 15(34) 
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TNM stage 0 11(3) 9(3) 0(0) 2(5) 0.459 
1 75(21) 66(24) 6(19) 3(7) 
2 140(40) 103(37) 16(52) 21(49) 
3 115(32) 89(32) 9(29) 17(40) 




No 112(37) 38(14) 12(40) 22(58) <0.001 
Yes 188(63) 242(86) 18(60) 16(42) 
Visceral 
obesity 
No 100(28) 58(20) 16(52) 26(62) <0.001 
Yes 258(72) 227(80) 15(48) 16(38) 
Low SMI No 175(50) 154(55) 12(40) 9(24) <0.001 
Yes 173(50) 126(45) 18(60) 29(76) 
Low SMD No 138(39) 116(41) 12(39) 10(24) 0.047 
Yes 220(61) 169(59) 19(61) 32(76) 
Inflammatory response  
mGPS 0 266(76) 226(80) 17(59) 23(55) <0.001 
1 39(11) 32(11) 3(10) 4(9) 
2 47(13) 23(8) 9(31) 15(36) 
NLR <3 184(51) 151(53) 13(42) 20(45) 0.038 
3-5 115(32) 92(32) 12(39) 11(25) 






No 227(63) 182(64) 18(58) 27(61) 0.682 
Yes 133(37) 103(36) 13(42) 17(39) 
Non infective 
complication 
No 301(84) 243(85) 25(81) 33(75) 0.077 
Yes 59(16) 42(15) 6(19) 11(25) 
Infective 
complication 
No 267(74) 214(75) 21(68) 32(73) 0.566 
Yes 93(26) 71(25) 10(32) 12(27) 
Clavien 
Dindo grade  
 
0 236(66) 191(67) 18(58) 27(61)  
0.285 1-2 102(28) 78(27) 12(39) 12(27) 
3-5 22(6) 16(6) 1(3) 5(11) 
Length of 
hospital stay  
≤ 7 days 165(46) 145(51) 11(36) 9(22) 0.001 
> 7 days 192(54) 141(49) 20(64) 31(78) 
Survival for 3 
years 
Alive 288(79) 239(83) 24(77) 25(67) 0.002 
All causes death 75(21) 49(17) 7(23) 19(33) 
  
1 
N(%), Chi test for linear by linear association. Significant value p<0.001. mGPS: modified Glasgow Prognostic Score. NLR: Neutrophil-to-lymphocyte Ratio. SMD: 






Table 2. The relationship between MUST, clinical and pathological characteristics and length of hospital stay (>7vs<7 days) in patients 




LOS Variable Univariate OR 
(95% CI) 
P value Multivariate) OR 
(95% CI) 
P value 
Age 1.389(1.05,1.82) 0.019 1.28(0.79,1.71) 0.176 
Sex 1.23 (0.81,1.87) 0.328 - - 
ASA 1.35(1.03,1.76) 0.026 1.22(0.87,1.72) 0.234 
TNM stage 1.01(0.80,1.28) 0.898 - - 
BMI 0.79 (0.63,0.99) 0.045 0.99(0.67,1.47) 0.972 
MUST 1.88(1.31,2.69) 0.001 2.17(1.45,3.26) <0.001 
Subcutaneous 
adiposity 
0.69(0.40,1.18) 0.183 - - 
Visceral obesity 0.66(0.41,1.07) 0.094 0.62(0.29,1.32) 0.217 
Low SMI 1.37(0.89,2.10) 0.142 - - 
Low SMD 1.09(0.70,1.67) 0.696 - - 
mGPS 1.38 (1.01,1.90) 0.043 0.99(0.67,1.47) 0.993 
NLR(<3/3-5/>5) 1.59(1.19,2.12) 0.002 1.26(0.88 ,1.80) 0.190 
Complication 9.10(5.26,15.75) <0.001 11.04(5.96,20.44) <0.001 
1
 Binary logistic regression, OR: odd ratio, variables associated to a degree of p<0.1 at univariate analysis were entered into a backward conditional multivariate model. 






















Binary logistic regression, OR: odd ratio, variables associated to a degree of p<0.1 at univariate analysis were entered into a backward conditional multivariate model. 
P<0.05 considered significant.  mGPS: modified Glasgow Prognostic Score. NLR: Neutrophil-to-lymphocyte Ratio. SMD: skeletal muscle radiodensity. SMI: skeletal muscle 
index 
OS Variable Univariate HR 
(95% CI) 
P value Multivariate HR 
(95% CI) 
P value 
Age 1.78 (1.32,2.42) <0.001 1.45(1.05,2.01) 0.023 
Sex 1.63(1.00,2.64) 0.048 1.61(0.91,2.85) 0.109 
ASA 1.64(1.24,2.17) <0.001 1.27(0.90,1.77) 0.271 
TNM stage 1.88(1.40,2.53) <0.001 2.19(1.56,3.08) <0.001 
BMI 0.71(0.56,0.90) 0.005 0.91(0.62,1.32) 0.749 
MUST 1.69(1.30,2.21) <0.001 1.45(1.06,1.99) 0.020 
Subcutaneous 
adiposity 
0.56(0.33,0.96) 0.033 0.87(0.42,1.82) 0.360 
Visceral obesity 0.81(0.49,1.33) 0.411 - - 
Low SMI 1.43(0.87,2.34) 0.155 - - 
Low SMD 1.88(1.13,3.14) 0.015 1.08(0.56,2.08) 0.848 
mGPS 1.52(1.13,2.06) 0.005 1.25(0.90,1.73) 0.303 
NLR(<3/3-5/>5) 1.38(1.03,1.85) 0.026 1.39(1.01,1.90) 0.037 
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Legends for figures : 
Figure 1: MUST score (Elia., 2003) (9) 
Figure 1. 
Risk group            Total score 
      Low risk                       0 
      Medium risk                 1 
      High risk                      2 or more 
 
Weight loss effect  score  
Unintentional Weight loss 
in the last 3-6 months  
 
Percent             score 
<5%                     0  
5-10%                  1  
>10%                   2 
 
Acute disease effect score 
If patient is acutely ill and 
there has been or is likely 
to be no nutritional 
intake for >5 days 
 






BMI                   s core 
>20 kg/m2                   0 
18.5-20 kg/m2       1 





Figure 2: Kaplan–Meier curves showing the relationship between MUST score and overall 
survival in patients with colorectal cancer (Median follow-up: 38 month. MUST score 0 n = 
288, MUST score 1 n = 31, MUST score >2 n = 44.  )   
 
 
